Hindié, Elif <br/><br/>
Optimising first-line treatment for metastatic renal cell carcinoma.  [electronic resource] 

 -  Lancet (London, England)  01 2020 
 - e6 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(19)32487-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Carcinoma, Renal Cell<br/>Humans<br/>Kidney Neoplasms<br/>Sunitinib